These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1847976)

  • 21. [Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin and cisplatin in unresectable stage III non small-cell lung cancer].
    Renard A; Noël G; Mazeron JJ
    Cancer Radiother; 2000; 4(4):317-8. PubMed ID: 10994396
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few.
    Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L
    J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of inoperable patients with non-small-cell lung cancer.
    Feld R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():19-24. PubMed ID: 7602831
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 25. Concurrent radiotherapy and chemotherapy in lung cancer at the Princess Margaret Hospital.
    Payne DG; Feld R
    Antibiot Chemother (1971); 1988; 41():96-101. PubMed ID: 2854451
    [No Abstract]   [Full Text] [Related]  

  • 26. Very low acute toxicity of three fractions per day accelerated radiotherapy given after induction chemotherapy and surgery in stage III non-small cell lung cancer.
    de Pas T; Catalano G; Pastorino U; de Braud F; Jereczek-Fossa B; Spaggiari L; Orecchi R
    Lung Cancer; 2000 Nov; 30(2):149-50. PubMed ID: 11185476
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy in stage III non-small cell lung cancer.
    Eberhardt WE; Hepp R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic treatment of non-small-cell lung cancer.
    Lal R; Enting D; Kristeleit H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S375-7. PubMed ID: 21944021
    [No Abstract]   [Full Text] [Related]  

  • 30. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of small cell lung cancer].
    Ueoka H; Ohnoshi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiation in unresectable stage III non-small cell lung cancer: too much pain for no gain.
    Dillman RO
    Cancer J Sci Am; 1996; 2(2):76-8. PubMed ID: 9166503
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of unresectable non-small cell carcinoma of the lung (NSCLC).
    Cox JD; Le Chevalier T; Arriagada R; Choy H; Curran WJ; Fukuoka M; Harper P; Komaki R; Le Pechoux C; Lievens Y; Rami-Porta R; Ready N; Sause W; Stuschke M; Thatcher N
    Lung Cancer; 2003 Dec; 42 Suppl 1():S15-6. PubMed ID: 14708518
    [No Abstract]   [Full Text] [Related]  

  • 34. Multidisciplinary management of lung cancer.
    Spira A; Ettinger DS
    N Engl J Med; 2004 Jan; 350(4):379-92. PubMed ID: 14736930
    [No Abstract]   [Full Text] [Related]  

  • 35. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 36. [Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
    Hou HL; Hao JL; Pang QS; Wang P
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2068-70. PubMed ID: 21029648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative therapy of non-small cell lung cancer: a review of adjuvant and neoadjuvant approaches.
    Friedland DM; Comis RL
    Semin Oncol; 1995 Dec; 22(6):571-81. PubMed ID: 8539633
    [No Abstract]   [Full Text] [Related]  

  • 39. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
    Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
    J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
    [No Abstract]   [Full Text] [Related]  

  • 40. Future directions and strategies.
    McVie JG
    Lung Cancer; 1995 Apr; 12 Suppl 1():S199-201. PubMed ID: 7551930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.